Immune Globulin Intravenous (IGIV) For Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

PHASE3CompletedINTERVENTIONAL
Enrollment

117

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

June 30, 2006

Study Completion Date

June 30, 2006

Conditions
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
Interventions
DRUG

Immune Globulin IV (Human), 10% Caprylate/Chromatography Purified

2 g/kg body weight ideally over 2-4 days . Thereafter, study drug infusion (IGIV-C) will be administered every 3 weeks at a dose of 1 g/kg bw, given over 1-2 days for a total of 7 additional infusions

DRUG

Albumin (Human) 25%, United States Pharmacopeia (USP)

Albumin 25%, USP diluted with dextrose 5% to a final concentration of 0.1% as an intravenous infusion. Alternatively, it may be a bottled placebo of 0.1% Albumin (Human) in 0.2 M Glycine, 1.1 mm sodium caprylate, 0.25% sodium chloride. 2 g/kg body weight ideally over 2-4 days . Thereafter, infusion (placebo) will be administered every 3 weeks at a dose of 1 g/kg bw, given over 1-2 days for a total of 7 additional infusions

Trial Locations (32)

1790

Fakultní nemocnice Ostrava, Ostrava-Poruba

10022

Columbia University, New York

11000

University Hospital, University of Belgrade, Belgrade

13347

Jüdisches Krankenhaus, Berlin

15600

Fakultní nemocnice Motol, Prague

16132

Univesita delgi Studi di Genova, Dipartimento di Scienze, Neurologiche e della Visione, Genova

20132

Hospital San Raffaele, Milan

44195

Cleveland Clinic, Cleveland

44280

Antiguo Hospital Civil de Guadalajara, Guadalajara

53003

Neurologická klinika Pardubice, Pardubice

63110

Saint Louis University Medical Center, St Louis

70300

Assaf Harofe Medical Center, Zrifin

75390

University of Texas-Southwestern Medical Center at Dallas, Dallas

84101

Tel Aviv Sourasky Medical Center, Tel Aviv

06520-8018

Yale University School of Medicine, New Haven

27157-1078

Wake Forest University-School of Medicine, Winston-Salem

C1221 ADC

Hospital Ramos Mejia, Buenos Aires

C1221ACI

Hospital Frances, Buenos Aires

C1428 AQK

Fundacion para la Lucha contra Las Enfermedades Neurologicas de la Infacia (FLENI), Buenos Aires

C1192 AAW

Instituto de Neurociencias Buenos Aires (INEBA), Capital Federal

V5Z 1M9

Vancouver Hospital and Health Sciences Center, Vancouver

625 00

Fakultní nemocnice Brno, Brno

Unknown

Chaim Sheba Medical Center, Tel Litwinsky

Dipartimento di Neuroscienze, Sezione di Neurologia, AO Chieti, Chieti

Hospital Angel Leano, Neurology Department, Guadalajara

Hospital Central San Luis Potosi, Neurology Department, San Luis Potosí City

Central Clinical Hospital, Medical Academy Warsaw, Warsaw

County Hospital, Zgierz

80-803

County Specialist Hospital, Neurology Department, Gdansk

31-530

Centre of Clinical Neurology, Neurology Department, Krakow

90-153

Barlicki Hospital, Lodz

20-950

Medical Acedemy, Clinical Hospital, Neurology Department, Lubin

Sponsors
All Listed Sponsors
lead

Grifols Therapeutics LLC

INDUSTRY

NCT00220740 - Immune Globulin Intravenous (IGIV) For Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) | Biotech Hunter | Biotech Hunter